Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

$93,000 cancer drug: How much is a life worth?
Yahoo/AP
Sun, 09/26/10 - 12:27 pm
Tags:
Provenge, Dendreon, Revlimid, Celgene
J&J Expands Options For Prostate Cancer
Yahoo/Investor's Business Daily
Sat, 09/25/10 - 12:08 pm
Tags:
JNJ, prostate cancer, abiraterone, Provenge, Dendreon
A Dendreon Deal: It's Not What You Think
Motley Fool
Wed, 09/22/10 - 03:48 pm
Tags:
Dendreon, GSK, Provenge, prostate cancer
Dendreon: Assessing New Threat to Provenge
TheStreet.com
Wed, 09/22/10 - 11:40 am
Tags:
Provenge, Dendreon, vaccines, prostate cancer, AstraZeneca, zibotentan
Dendreon signs Provenge supply deal with Glaxo
Bizjournals.com
Tue, 09/21/10 - 01:17 pm
Tags:
Dendreon, Provenge, GSK, prostate cancer, vaccines
Rodman Rambles: Promising Biotechs
TheStreet.com
Wed, 09/15/10 - 10:55 am
Tags:
AVI BioPharma, Athersys, BioDelivery Sciences, Dendreon, Neoprobe, RXi Pharmaceuticals, Polymedics, Alexion, Biomarin
Did Dendreon Open Doors For Opexa Partnerships?
Yahoo/IndieResearch
Mon, 09/13/10 - 04:02 pm
Tags:
Opexa, Dendreon, stem cells, Novartis
J&J Prostate Cancer Drug Boosts Survival
TheStreet.com
Fri, 09/10/10 - 11:07 am
Tags:
JNJ, prostate cancer, abiraterone, Dendreon, Provenge
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
Tags:
diet drugs, biotech, Arena Pharmaceuticals, Dendreon, Provenge, Exelixis, Vivus, Orexigen, Takeda, Contrave, Martek
Dendreon Shares Up on Provenge Medicare Coverage Meeting Scheduling
WSJ Online
Thu, 09/2/10 - 10:02 am
Tags:
Dendreon, Provenge, prostate cancer, Medicare
Dendreon: Medicare Coverage Fears Allayed
TheStreet.com
Wed, 09/1/10 - 08:07 am
Tags:
Dendreon, Medicare, Provenge, prostate cancer
These Are the Top 10 Pharma Underperform Calls
Motley Fool
Thu, 08/26/10 - 08:03 pm
Tags:
Dendreon, Human Genome, Targacept, Vanda, Pharmacyclics, Acorda Therapeutics, MannKind
Senators Ask Why Medicare Is Reviewing Provenge
Pharmalot
Thu, 08/26/10 - 10:36 am
Tags:
Senate, Medicare, Dendreon, prostate cancer, Provenge
Dividends Aren't Enough: Biotech
Motley Fool
Sat, 08/21/10 - 10:48 am
Tags:
Gilead Sciences, Amgen, Genzyme, Dendreon, Biogen Idec
Dividends Aren't Enough: Biotech
Motley Fool
Fri, 08/20/10 - 12:48 pm
Tags:
biotech, Gilead Sciences, Amgen, Genzyme, Biogen Idec, Dendreon
Dendreon’s Big Pharma Future
Motley Fool
Wed, 08/18/10 - 02:32 pm
Tags:
Dendreon, Provenge, vaccines, prostate cancer
Technically, Dendreon Is a Buy
Motley Fool
Tue, 08/17/10 - 03:16 pm
Tags:
Dendreon
Dendreon's in Trouble
Motley Fool
Mon, 08/9/10 - 08:16 pm
Tags:
Provenge, FDA, prostate cancer, Dendreon
Kaleetan Seeks to Stand on Dendreon's Shoulders
Motley Fool
Mon, 08/9/10 - 02:27 pm
Tags:
Kaleetan, Dendreon
3 Stocks to Play Biotech
Motley Fool
Mon, 08/9/10 - 02:17 pm
Tags:
Dendreon, ONYX Pharmaceuticals, Geron, Isis Pharmaceuticals, InterMune

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.